Close Menu

NEW YORK (360Dx) – The Japanese Red Cross Society (JRC) inked an eight-year contract to make Abbott an exclusive supplier of immunoassay-based serological instrumentation, tests, and consumables for blood and plasma screening in Japan, Abbott said today.

The JRC will use Abbott's technology to screen each donation across eight distinct assays, including those used in hepatitis and retrovirus analysis.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.